Pfizer Gets Stay Of India Patent Withdrawal Of Detrol Incontinence Drug
This article was originally published in PharmAsia News
Executive Summary
India's Intellectual Property Appellate Board blocked temporarily the Indian Patent Office from withdrawing Pfizer Health AB's patent for Detrol (tolterodine), a treatment for overactive bladder symptoms.